Robeco Schweiz AG Sells 16,118 Shares of Maximus, Inc. $MMS

Robeco Schweiz AG lowered its stake in Maximus, Inc. (NYSE:MMS) by 15.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 86,021 shares of the health services provider’s stock after selling 16,118 shares during the quarter. Robeco Schweiz AG’s holdings in Maximus were worth $7,860,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of MMS. Royal Bank of Canada raised its stake in shares of Maximus by 146.2% during the 1st quarter. Royal Bank of Canada now owns 19,732 shares of the health services provider’s stock worth $1,345,000 after purchasing an additional 11,716 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock worth $2,351,000 after buying an additional 221 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Maximus by 7.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 180,690 shares of the health services provider’s stock worth $12,321,000 after acquiring an additional 11,754 shares in the last quarter. Jane Street Group LLC lifted its stake in Maximus by 941.2% in the first quarter. Jane Street Group LLC now owns 98,273 shares of the health services provider’s stock valued at $6,701,000 after acquiring an additional 88,835 shares during the last quarter. Finally, Strs Ohio acquired a new position in shares of Maximus during the 1st quarter worth about $252,000. 97.21% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several brokerages recently issued reports on MMS. Weiss Ratings reiterated a “buy (b-)” rating on shares of Maximus in a research note on Monday, December 29th. Zacks Research upgraded Maximus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 30th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to MarketBeat, the company has an average rating of “Strong Buy”.

Insider Activity

In other news, insider Michelle F. Link sold 4,039 shares of the firm’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the transaction, the insider directly owned 19,542 shares of the company’s stock, valued at approximately $1,697,027.28. This trade represents a 17.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by insiders.

Maximus Trading Down 0.3%

Shares of MMS stock opened at $96.28 on Wednesday. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $97.41. The company has a market capitalization of $5.24 billion, a PE ratio of 17.32 and a beta of 0.56. The firm has a 50 day moving average price of $86.02 and a two-hundred day moving average price of $83.71. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.77.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.01). The firm had revenue of $1.32 billion for the quarter, compared to analyst estimates of $1.34 billion. Maximus had a return on equity of 25.23% and a net margin of 5.87%.The business’s revenue for the quarter was up .2% on a year-over-year basis. During the same period in the previous year, the business posted $1.46 earnings per share. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. As a group, analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.32 dividend on an annualized basis and a yield of 1.4%. This is an increase from Maximus’s previous quarterly dividend of $0.30. Maximus’s payout ratio is presently 23.74%.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.